Hosztafi S - Search Results

1

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.

Balogh M, Zádor F, Zádori ZS, Shaqura M, Király K, Mohammadzadeh A, Varga B, Lázár B, Mousa SA, Hosztafi S, Riba P, Benyhe S, Gyires K, Schäfer M, Fürst S, Al-Khrasani M. Balogh M, et al. Among authors: hosztafi s. Front Pharmacol. 2019 Apr 9;10:347. doi: 10.3389/fphar.2019.00347. eCollection 2019. Front Pharmacol. 2019. PMID: 31024314 Free PMC article.

2

Irreversible blockade of the high and low affinity (3H) naloxone binding sites by C-6 derivatives of morphinane-6-ones.

Krizsan D, Varga E, Hosztafi S, Benyhe S, Szucs M, Borsodi A. Krizsan D, et al. Among authors: hosztafi s. Life Sci. 1991;48(5):439-51. doi: 10.1016/0024-3205(91)90500-b. Life Sci. 1991. PMID: 1992286

3

Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro.

Benyhe S, Hoffmann G, Varga E, Hosztafi S, Toth G, Borsodi A, Wollemann M. Benyhe S, et al. Among authors: hosztafi s. Life Sci. 1989;44(24):1847-57. doi: 10.1016/0024-3205(89)90302-0. Life Sci. 1989. PMID: 2472540

4

Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity.

Friedmann T, Tóth Z, Hosztafi S, Simon CS, Makleit S, Fürst S. Friedmann T, et al. Among authors: hosztafi s. Arch Int Pharmacodyn Ther. 1994 Jul-Aug;328(1):16-25. Arch Int Pharmacodyn Ther. 1994. PMID: 7893188

5

Binding properties of the pure opioid antagonist [3H](N-propyl)-noroxymorphone in rat brain membranes.

Tóth G, Benyhe S, Hosztafi S, Borsodi A. Tóth G, et al. Among authors: hosztafi s. Neurobiology (Bp). 1993;1(4):327-35. Neurobiology (Bp). 1993. PMID: 8069290

6

Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.

Riba P, Tóth Z, Hosztafi S, Friedmann T, Fürst S. Riba P, et al. Among authors: hosztafi s. Acta Biol Hung. 2003;54(2):177-81. doi: 10.1556/ABiol.54.2003.2.6. Acta Biol Hung. 2003. PMID: 14535623

7

The chemical and pharmacological importance of morphine analogues.

Fürst S, Hosztafi S. Fürst S, et al. Among authors: hosztafi s. Acta Physiol Hung. 2008 Mar;95(1):3-44. doi: 10.1556/APhysiol.95.2008.1.1. Acta Physiol Hung. 2008. PMID: 18389996 Review.

8

A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.

Lacko E, Varadi A, Rapavi R, Zador F, Riba P, Benyhe S, Borsodi A, Hosztafi S, Timar J, Noszal B, Furst S, Al-Khrasani M. Lacko E, et al. Among authors: hosztafi s. Curr Med Chem. 2012;19(27):4699-707. doi: 10.2174/092986712803306376. Curr Med Chem. 2012. PMID: 22934777

9

Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.

Khalefa BI, Mousa SA, Shaqura M, Lackó E, Hosztafi S, Riba P, Schäfer M, Ferdinandy P, Fürst S, Al-Khrasani M. Khalefa BI, et al. Among authors: hosztafi s. Eur J Pharmacol. 2013 Aug 5;713(1-3):54-7. doi: 10.1016/j.ejphar.2013.04.043. Epub 2013 May 9. Eur J Pharmacol. 2013. PMID: 23665110

10

A new potent analgesic agent with reduced liability to produce morphine tolerance.

Kiraly K, Caputi FF, Hanuska A, Kató E, Balogh M, Köles L, Palmisano M, Riba P, Hosztafi S, Romualdi P, Candeletti S, Ferdinandy P, Fürst S, Al-Khrasani M. Kiraly K, et al. Among authors: hosztafi s. Brain Res Bull. 2015 Aug;117:32-8. doi: 10.1016/j.brainresbull.2015.07.005. Epub 2015 Jul 30. Brain Res Bull. 2015. PMID: 26235542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters